Schedule 13G ownership disclosure

Maze Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 578784100

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Matrix Capital Management Company, LP

    Shares: 1,653,684.00 · Class: 3.5%

  • DAVID E. GOEL

    Shares: 1,653,684.00 · Class: 3.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-004912
Form type
SCHEDULE 13G/A
Filer
Matrix Capital Management Company, LP
CIK
CIK 1410830
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub